BIOWeek:Boston 2018 The Complete Guide to the Week of the BIO International Convention June 3-8, 2018 Big3Bio Releases The First Version of BIOWeek:Boston 2018, The Complete Guide to the Week of #BIO2018 SAN FRANCISCO, CA–(May 25, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay […]
Big3Bio Publishes BIOWeek:Boston 2018, The Complete Guide to the Week of #BIO2018
/ big4bio
SAN FRANCISCO, CA–(May 25, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the first version of BIOWeek:Boston 2018, the compendium of everything going on during the week of the BIO International Convention (#BIO2018), June 3-8. BIOWeek:Boston 2018 not only lists/links all of the major conferences occurring […]
Event Recap: QB3 Seminar May 15, 2018 on Why Do Diagnostic Companies Fail?
/ big4bio
Urdea Talks About Why Diagnostics Companies Fail By Marie Daghlian The classroom at QB3 on the UCSF campus was small, only sixty seats, but it was packed—all the seats were taken and at least thirty more people lined the walls and sat in the center aisle. Before introducing Mickey Urdea, health sciences incubator QB3 Executive […]
May Financial Focus: San Diego Early-Stage Funding Soars in First Quarter of 2018
/ big4bio
By Marie Daghlian Early stage venture financing in the San Diego area experienced a massive boom in capital raised in the first quarter of 2018 as four biotech companies raised an impressive $240 million. It was more than twice the amount raised in early stage rounds in all of 2017. Early Stage Venture Capital Funding […]
May Financial Focus: Boston Area a Hot-Bed for Biopharma Startups
/ big4bio
By Marie Daghlian VC funding for Boston area biotech companies is on fire and its momentum shows no signs of slowing up. Boston area biotech and health-related companies raised $1.58 billion in 32 deals in the first quarter of 2018. That compares favorably with the $1.59 billion raised in Q4 2017 in 42 deals, and […]
May Financial Focus: While VC Funding Continues to Flow Into SF Bay Area Biotech Companies, Early Stage Funding Slows
/ big4bio
By Marie Daghlian The San Francisco Bay Area continues to be a hotbed of company formation and financing not only in tech but also in biotech. Biotech and health-related companies raked in $1.2 billion in venture capital financing in the Q1 2018 in 32 deals. While it was less than the $1.7 billion raised in […]